Motor cortex transcriptome reveals microglial key events in amyotrophic lateral sclerosis

Oriol Dols-Icardo1, Víctor Montal2, Sònia Sirisi2

  • 1From the Memory Unit (O.D.-I., V.M., S.S., G.L.-P., L.C.-C., M.Q.-V., L.M., O.B., D.A., J.P., R.B., A.L., J.F., J.C.), Neurology Department and Sant Pau Biomedical Research Institute, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona; Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED) (O.D.-I., V.M., S.S., G.L.-P., L.C.-C., M.Q.-V., L.M., O.B., D.A., J.P., R.B., A.L., J.F., J.C.), Madrid; Neurological Tissue Bank of the Biobanc-Hospital Clínic-IDIBAPS (L.M.-P.), Barcelona; Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Department (L.M.-P.), Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona; Network Center for Biomedical Research in Rare Diseases (CIBERER) (J.T.-S., R.R.-G.), Madrid; and Neuromuscular Disorders Unit (J.T.-S., R.R.-G.), Department of Neurology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Spain. jclarimon@santpau.cat odols@santpau.cat.

Summary

Disease-associated microglia (DAM) drive neuroinflammation in the motor cortex of amyotrophic lateral sclerosis (ALS) patients, alongside reduced synaptic gene expression.

Related Concept Videos